SB
Sunshine Biopharma, Inc.
SBFM · NASDAQ
$0.90 +9.73% (+$0.08)
1M -22.43%
Market Cap $2.14M
P/E Ratio -
Div. Yield -
ROE 24.23%
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/S 0.06x
P/B 0.08x
P/E N/A
Growth
86 /100
Growing Rev. growth 102.91%
Book val. growth 2.13%
EPS growth N/A
Profitability
11 /100
Weak Gross margin 29.80%
Net margin 16.50%
FCF margin 13.01%
Quality
13 /100
Poor ROIC 19.32%
ROE 24.23%
Asset turnover 1.05x
Debt
100 /100
Low Debt/Equity 0.02x
Current ratio 5.46x
Int. coverage N/A
Stability
43 /100
Moderate Beta 1.32x
Rev. volatility 249.09%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about SBFM
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Steve N. Slilaty
Employees
50
Headquarters
Fort Lauderdale
Upcoming events
12 NOV
Earnings
Upcoming earnings report